{"SPADE_N_07190": {"Clinical Information": [], "Patent Information": [], "Sequence Information": {"SPADE ID": "SPADE_N_07190", "Peptide Name": "PEDF-TGA fragment", "Source": "PEDF", "Family": "", "Gene": "Not found", "Sequence": "TGALVEEEDPF", "Sequence Length": 11, "UniProt Entry": ["http://www.uniprot.org/uniprot/Notavailable"], "Protein Existence": "Not found", "Biological Activity": ["Antimicrobial", "Anticancer"], "Target Organism": "Not available", "Hemolytic Activity": "Not available", "Cytotoxicity": "Not available", "Binding Target": "Not available", "Linear/Cyclic": "", "N-terminal Modification": "Free", "C-terminal Modification": "Free", "Stereochemistry": "L", "Structure Description": "Not found", "Formula": "C53H79N11O21", "Mass": 1206.26, "PI": 4.05, "Net Charge": -4, "Hydrophobicity": -0.37, "Half Life": "Mammalian:7.2 hourYeast:>20 hourE.coli:>10 hour", "Literature": [{"Title": "Anti-angiogenic peptides for cancer therapeutics", "Pubmed ID": "21470139", "Reference": "Curr Pharm Biotechnol. 2011 Aug;12(8)1101-31.", "Author": "Rosca EV, Koskimaki JE, Rivera CG, Pandey NB, Tamiz AP, Popel AS", "URL": "http://www.ncbi.nlm.nih.gov/pubmed/?term=21470139"}], "Frequent Amino Acids": "EAD", "Absent Amino Acids": "CHIKMNOQRSUWY", "Basic Residues": 0, "Acidic Residues": 4, "Hydrophobic Residues": 5, "Polar Residues": 3, "Positive Residues": 0, "Negative Residues": 4, "Similar Sequences": [{"SPADE_ID": "SPADE_N_08780", "Similarity": 1.0, "Sequence": "GLLDSVKEGLKKVAGQLLDTLKCKISGCTGA"}, {"SPADE_ID": "SPADE_N_13762", "Similarity": 1.0, "Sequence": "ACSSSSPCPGNQCCSKWGYCGLGGDYCGSGCQSGPCTGA"}, {"SPADE_ID": "SPADE_N_15435", "Similarity": 1.0, "Sequence": "GTGA"}]}}}